What’s happening: CHA has filed an amicus (“friend of the court”) brief with 36 other state and regional hospital associations supporting the Health Resources and Services Administration (HRSA) against pharmaceutical manufacturers’ appeal of rulings related to 340B Drug Pricing Program rebate models.
This content is restricted to members.
